Overview
Roche Polska focuses on discovering new medicines, diagnostics and digital healthcare solutions. The company develops medicines, therapies and diagnostic solutions, conducts clinical research and has used energy exclusively from renewable sources in its buildings since 2024.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
17 1880 0009 0000 0011 0283 5000
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 30, 2014 | Return of additional payments |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
1335 tenders recorded as contractor: 180 national ($12,340,797) and 1155 EU ($8,427,506,646).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 2, 2026 | Dostawa leków do chemioterapii i programów lekowych 2026-2028 | — | Wojewódzki Szpital Specjalistyczny We Wrocławiu | |
| Oct 2, 2026 | Dostawa leków programowych, onkologicznych, płynów infuzyjnych, erytropoetyny oraz kontrastów | — | Wojewódzki Szpital Specjalistyczny Nr 4 w Bytomiu | |
| Oct 2, 2026 | Zakup i sukcesywna dostawa leków onkologicznych oraz leków różnych. | — | Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Two members of the management board jointly, or one member of the management board together with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Roche Finanz Ag | 25,000 | $6,753,106.43 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Isabel Marianne Joerin (38)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Irma Veberič (57)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Ehab Abdelmoneim Youssef Hassan (61)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
Selected automatically: mainly by similarity of the business description, plus comparable revenue, industry (PKD code) and location. Only companies with a complete profile (including a logo and financial data) are shown. The list is indicative.
| Name | Revenue | Website | |
|---|---|---|---|
| NeucaS.A. | $3,426,322,199.90 | inwestor.neuca.pl | |
| Bayersp. z o.o. | $624,313,880.67 | bayer.pl | |
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.pl | |
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | |
| Servier Polska Servicessp. z o.o. | $125,526,921.78 | servier.pl |
Change history
| Date | Event |
|---|---|
| 2023-01-16 | Address change (Domaniewska 39b, 02-672, Warszawa → Ul. Domaniewska 28, 02-672, Warszawa) |
| 2009-02-16 | Share capital change (2,000,000.00 PLN → 25,000,000.00 PLN) |
| 2006-03-07 | Address change (Al. Jerozolimskie 146b, 02-305, Warszawa → Domaniewska 39b, 02-672, Warszawa) |
| 2002-06-14 | Entered in the register |
FAQ
Last updated: 2026-04-05